Most Alzheimer’s drugs in development target beta-amyloid, but targeting another protein, called tau, may be needed.
Andre Berndt is recognized by the 2022 McKnight award for work that “fundamentally changes way neuroscience is conducted.”
The drug erythropoietin, when combined with cooling therapy, showed no added benefits, study finds.
Researchers hope to use brain stimulation to create new neuronal cell networks to restore function lost due to stroke.
Research program analyzes cerebrospinal fluid molecules to seek diagnostic and progression markers as well as treatment targets.
An ancestral African population reveals clues to the genetic origins of schizophrenia
As we recover from the effects of daylight-saving time, some may take a melatonin supplement at supper to help with sleep.
Elements of computerized neural networks seem to respond in the same way as neurons in the brain’s visual system, researchers find.
Injuries to a former Russian agent and his daughter lead to several nations expelling Russian diplomats.
The identifier "population neuroscience" evokes the collaboration needed to make headway against brain diseases, says UW Alzheimer's expert.
